Unconventional Increase in Non-Radiative Transitions in Plasmon-Enhanced Luminescence: A Distance-Dependent Coupling

Multitherapeutic nanoplatform based on scintillating anthracene, silver@anthracene, and gold@anthracene nanoparticles for combined radiation and photodynamic cancer therapies

We have synthesized anthracene and metal@anthracene core-shell nanoparticles to combine radiation (RT) and photodynamic (PDT) therapies. Synthesis of anthracene nanoparticles in the presence of colloidal silver or gold reduced the nanoparticles hydrodynamic radius, caused core-shell nanostructures to grow, and led to plasmon-enhanced fluorescence. Singlet oxygen (¹O₂) generation was investigated by electron spin resonance (ESR) and fluorescence spectroscopies. In the presence of a porphyrin, anthracene nanoparticles and the core-shell nanoparticles acted as energy mediators and increased ¹O₂ generation under exposure to light, as evidenced by the ESR results. Fluorescence suppression experiments showed that the core-shell nanoparticles captured ¹O₂ at rates higher than anthracene nanoparticles, suggesting that overall production of ¹O₂ (¹O₂ captured by spin-trap + ¹O₂ captured by surface anthracene molecules) was higher for the core-shell nanoparticles. Moreover, the Ag@anthracene nanoparticles stood out as a new and more sensitive fluorescent probe for ¹O₂. During irradiation with X-rays, both anthracene and Ag@anthracene nanoparticles trapped ¹O₂; subsequently, they afforded sustained release of the trapped ¹O₂ for up 12 days after irradiation. This could be an interesting strategy to extend the radiation therapy treatment after the irradiation sessions. Furthermore, the presence of the metallic nanoparticle in the core of the core-shell nanostructure increased interaction with X-rays, raising the radiation dose around the nanoparticle. Therefore, metal@anthracene nanostructures may allow combination of cancer treatments by different approaches depending on the adopted nanoparticle configuration.

Monosodium glutamate for accidental, retrospective, and medical dosimetry using electron spin resonance

The risk of a radiation episode has increased in the last years due to several reasons. In case of a nuclear incident, as with the use of an improvised nuclear device, determination of the radiation doses received by the victims is of utmost importance to define the appropriate medical treatment or to monitor the late effects of radiation. Dose assessment in case of accidents can be performed using commonplace materials found in the accident area. In this paper, the dosimetric properties of monosodium glutamate are investigated by electron spin resonance spectroscopy (ESR), for retrospective and accidental dosimetry. The spectroscopic parameters were optimized to achieve higher signal intensity and better signal-to-noise ratio. As a result, the lowest detectable dose was 0.1 Gy, and monosodium glutamate showed a linear dose-response curve for doses ranging from 0.1 Gy to 10 kGy. The dosimetric signal was monitored from minutes right after irradiation, until 1 year. No changes in the signal intensity were observed over this period, meaning that doses could be assessed immediately after radiation exposure and can still be reconstructed long after the accident. This property also implies that late effects due to victim's radiation exposure could be better monitored and understood. ESR signal intensity for samples irradiated with a photon energy below 100 keV was decreased by only 27% and no dose-rate dependence was noticed. Therefore, the ability to measure doses as low as 0.1 Gy, the high stability of the dosimetric signal, as well as independence on dose rate, tissue equivalence, low-cost, and wide commercial availability make monosodium glutamate a very good dosimetric material not only for retrospective and accidental but also for medical dosimetry.